What's Happening?
A recent study from the University of Florida, published in Nature Metabolism, has found that glucosamine, a supplement commonly used by older adults for joint pain, may accelerate the progression of Alzheimer's disease. The research indicates that individuals
with mild cognitive impairment who take glucosamine are 25% more likely to develop dementia compared to non-users. Additionally, among those already diagnosed with Alzheimer's, glucosamine use is associated with a 25% increase in mortality risk. Dr. Jessica McCarthy, a neuropsychologist, highlighted concerns about the interaction of supplements with existing health conditions and medications, emphasizing the need for caution in their use.
Why It's Important?
The findings of this study are significant as they challenge the perceived safety of glucosamine, a widely used supplement among older adults, the demographic most at risk for Alzheimer's. The potential link between glucosamine and accelerated Alzheimer's progression could impact public health recommendations and consumer behavior regarding supplement use. This research underscores the importance of understanding the metabolic and inflammatory pathways involved in Alzheimer's, which could lead to more targeted therapeutic strategies. The study also raises awareness about the need for careful consideration of over-the-counter supplements, especially in populations with pre-existing health conditions.
